April 04, 2018
It’s well known that different people can react differently to the same drug, with some patients feeling no effect – and some experiencing unwanted, even fatal, reactions. Now that reading patients’ DNA has become cheap and easy, writes Carolyn Abraham, pressure is mounting to make gene-guided prescriptions a regular part of publicly funded medicine.
Source: Globe and Mail
http://ow.ly/f4Gf30j6JPi